CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.45 USD
+0.07 (5.07%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $1.45 0.00 (0.00%) 4:32 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | 0.17 |
Last EPS Surprise | 383.33% |
ABR | 1.86 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.14 |
Next Year | -0.47 |
EPS (TTM) | 0.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 21.79M | 22.19M | 106.81M | 84.07M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 41.46M | 41.46M | 152.45M | 101.46M |
Low Estimate | 10.00M | 12.00M | 78.96M | 50.00M |
Year ago Sales | 24.72M | 26.38M | 101.21M | 106.81M |
Year over Year Growth Est. | -11.84% | -15.88% | 5.52% | -21.29% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.08 | -0.14 | -0.47 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | 0.08 | 0.07 | 0.20 | -0.34 |
High Estimate | 0.16 | 0.15 | 0.29 | -0.28 |
Low Estimate | -0.25 | -0.22 | -0.54 | -0.61 |
Year ago EPS | -0.02 | 0.04 | -0.01 | -0.14 |
Year over Year Growth Est. | -250.00% | -300.00% | -1,300.00% | -235.71% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.08 | -0.14 | -0.47 |
7 Days Ago | -0.07 | -0.08 | -0.14 | -0.47 |
30 Days Ago | -0.07 | -0.08 | -0.14 | -0.47 |
60 Days Ago | -0.07 | -0.08 | -0.20 | -0.48 |
90 Days Ago | -0.03 | -0.05 | -0.21 | -0.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.07 | -0.08 | -0.14 | -0.47 |
Zacks Consensus Estimate | -0.07 | -0.08 | -0.14 | -0.47 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.17 | 0.01 | 0.04 | -0.02 | NA |
Estimate | -0.06 | 0.02 | -0.17 | -0.19 | NA |
Difference | 0.23 | -0.01 | 0.21 | 0.17 | 0.15 |
Surprise | 383.33% | -50.00% | 123.53% | 89.47% | 136.58% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more